Mercado mundial de medicamentos Tamiflu (fosfato de oseltamivir): tendencias de la industria y pronóstico hasta 2029

Análisis y tamaño del mercado                              

El mercado del tamiflu (fosfato de oseltamivir) está cambiando a medida que las organizaciones de atención médica, particularmente en los Estados Unidos, están cambiando cada vez más a la distribución de medicamentos sin receta. Como Estados Unidos es una de las economías de más rápido crecimiento de América del Norte, se prevé que tenga el segundo mayor ingreso en el mercado del tamiflu (fosfato de oseltamivir) para 2027. Como resultado, las corporaciones en los Estados Unidos están sacando provecho de la tendencia de cambio a medicamentos sin receta. Según los actores destacados del mercado, incluso las empresas de los mercados emergentes se esfuerzan por cambiar a medicamentos sin receta y realizar transacciones estratégicas para introducir avances en el tamiflu (fosfato de oseltamivir).

Data Bridge Market Research analiza que el mercado de medicamentos tamiflu (fosfato de oseltamivir) se valoró en USD 542,88 mil millones en 2021 y se espera que alcance los USD 862,85 mil millones para 2029, registrando una CAGR del 5,40% durante el período de pronóstico de 2022 a 2029. Además de los conocimientos del mercado, como el valor de mercado, la tasa de crecimiento, los segmentos del mercado, la cobertura geográfica, los actores del mercado y el escenario del mercado, el informe de mercado curado por el equipo de Data Bridge Market Research también incluye un análisis de expertos en profundidad, epidemiología del paciente, análisis de la cartera, análisis de precios y marco regulatorio.

Alcance del informe y segmentación del mercado

Market Definition

Tamiflu is an antiviral medicine that can be used to treat influenza. Tamiflu is an antiviral drug that works by suppressing the neuraminidase enzyme in the body, which aids in viral reproduction. This medicine stops new viruses from infecting host cells and activates enzymes (neuraminidases) found inside live organisms' cell membranes responsible for releasing offspring viruses after an infection with any organism. Furthermore, regular tamiflu treatment minimizes the severity of flu-related complications such as nausea, vomiting, and diarrhoea, lowering the risk of hospitalization due to viral fever or other influenza-related symptoms.

Tamiflu (Oseltamivir Phosphate) Drugs Market Dynamics

Drivers

• Rise in the prevalence of influenza diseases

The surging prevalence of influenza diseases is a major factor driving the tamiflu (oseltamivir phosphate) drugs market's growth rate during the forecast period of 2022-2029. According to the Centers for Disease Control and Prevention (CDC), the flu affects between 5% and 20% of the population in the United States each year. In addition, 200,000 individuals are hospitalized in the United States each year due to flu infection, with 36,000 of them dying from flu complications. Tamiflu is used to treat acute and uncomplicated influenza A and B in patients aged 2 weeks and older who have been symptomatic for less than 48 hours. It is also prescribed for the prevention of influenza A and B in patients aged one year and up.

• Increasing investment for healthcare infrastructure

Another significant factor influencing the growth rate of tamiflu (oseltamivir phosphate) drugs market is the rising healthcare expenditure which helps in improving its infrastructure. Following COVID-19, people's attitudes around health have shifted significantly. People's attitudes are evolving from disease treatment to disease prevention, and their total awareness of such drugs is increasing day by day. Governments around the world are investing more funding to improve and develop new healthcare infrastructure. Healthcare spending in the United States is expected to surpass 20% of GDP by 2028. All of these factors are estimated to drive the tamiflu (oseltamivir phosphate) drugs market forward.

Furthermore, rising initiatives by public and private organizations to spread awareness and rising healthcare expenditure will expand the tamiflu (oseltamivir phosphate) drugs market. Additionally, sedentary lifestyle of people and surging geriatric population will result in the expansion of tamiflu (oseltamivir phosphate) drugs market.

Opportunities

• Increase in the number of research and development activities         

The rising research and development activities are estimated to create new opportunities for the tamiflu (oseltamivir phosphate) drugs market growth in coming years.

Moreover, rising investment for the development of advanced technologies and increase in the number of emerging markets will further provide beneficial opportunities for the tamiflu (oseltamivir phosphate) drugs market growth during the forecast period.

Restraints/Challenges

• Side effects associated with tamiflu (oseltamivir phosphate) drugs

Side effects associated with tamiflu (oseltamivir phosphate) drugs will obstruct the growth rate of market. Severe side effects from oseltamivir include nausea, gastroenteritis, and stomach discomfort. It can lead to life-threatening health consequences in some situations, including heart attack, severe liver disease, and kidney problems. These limitations have the potential to stifle overall market growth.

On the other hand, the lack of healthcare infrastructure in developing economies and dearth of skilled professionals will challenge the tamiflu (oseltamivir phosphate) drugs market. Additionally, strict government regulations and the high cost of tamiflu (oseltamivir phosphate) drugs will restrain and further impede the growth rate of market during the forecast period of 2022-2029.

This tamiflu (oseltamivir phosphate) drugs market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the tamiflu (oseltamivir phosphate) drugs market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Patient Epidemiology Analysis

Tamiflu (oseltamivir phosphate) drugs market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Impacto de la COVID-19 en el mercado de medicamentos a base de Tamiflu (fosfato de oseltamivir)

El brote de COVID-19 y el consiguiente confinamiento en numerosos países del mundo tuvieron un enorme impacto en la situación financiera de las empresas de todos los sectores. El sector de la atención sanitaria privada es uno de los ámbitos en los que la pandemia tuvo un impacto significativo.

El brote del virus COVID-19 ha impulsado el mercado de los medicamentos a base de tamiflu (fosfato de oseltamivir). La rápida propagación de la enfermedad respiratoria aguda grave COVID-19 en la población inmunológica humana ha provocado una pandemia mundial. Las partículas de COVID-19 pueden sobrevivir durante varios días en las superficies, aunque al ser virus envueltos, son susceptibles a la desecación y la desinfección con detergentes suaves. Debido a que las secreciones nasales contienen el virus propagable, la progresión de la enfermedad y la contagiosidad parecen alcanzar su punto máximo antes o inmediatamente después de la aparición de los síntomas. Los medicamentos orales contra la COVID-19 pueden fabricarse, transportarse y almacenarse fácilmente, lo que hace que sea más cómodo obtenerlos y usarlos. Los antivirales, como el Tamiflu, se toman lo antes posible para reducir el riesgo de una enfermedad grave. La estrategia de Tamiflu para tratar la COVID-19 tiene varias ventajas sobre los medicamentos actuales que requieren infusiones intravenosas, incluidos los anticuerpos monoclonales y el plasma convaleciente.

Alcance del mercado mundial de medicamentos Tamiflu (fosfato de oseltamivir)

El mercado de medicamentos a base de tamiflu (fosfato de oseltamivir) está segmentado en función de la indicación, la forma de dosificación, la clase de medicamento, el tipo, la demografía del paciente, la vía de administración, los usuarios finales y el canal de distribución. El crecimiento entre estos segmentos le ayudará a analizar los segmentos de crecimiento reducidos en las industrias y brindará a los usuarios una valiosa descripción general del mercado y conocimientos del mercado para ayudarlos a tomar decisiones estratégicas para identificar las principales aplicaciones del mercado.

Clase de droga

• Inhibidores de la neuraminidasa
• Otros

Tipo

• De marca
• Genérico

Demografía del paciente

• Adultos
• Geriátrico
• Pediátrico

Forma de dosificación

• Cápsula
• Suspensión

Indicación

• Gripe A
• Gripe B
• Otros

Vía de administración

• Oral
• Parenteral
• Otros

Usuarios finales

• Hospitales
• Clínicas de especialidades
• Cuidado domiciliario
• Otros

Canal de distribución

• Farmacia hospitalaria
• Farmacia minorista
• Farmacia en línea
• Otros

Análisis y perspectivas regionales del mercado de medicamentos Tamiflu (fosfato de oseltamivir)

Se analiza el mercado de medicamentos Tamiflu (fosfato de oseltamivir) y se proporcionan información y tendencias del tamaño del mercado por país, indicación, forma de dosificación, clase de medicamento, tipo, demografía del paciente, vía de administración, usuarios finales y canal de distribución como se mencionó anteriormente.

The countries covered in the tamiflu (oseltamivir phosphate) drugs market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

North America dominates the tamiflu (oseltamivir phosphate) drugs market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period,due to the presence of major key players and rising healthcare expenditure will further propel the market’s growth rate in this region. Additionally, an increase in the number of FDA-approved drugs and high prevalence of influenzas illness will further propel the market’s growth rate in this region.

Asia-Pacific is expected to grow during the forecast period of 2022-2029 due to surging level of disposable income in this region. Also, development of healthcare infrastructure and rise in number of generic manufacturers will further propel the market’s growth rate in this region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Tamiflu (Oseltamivir Phosphate) Drugs Market Share Analysis

The tamiflu (oseltamivir phosphate) drugs market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to tamiflu (oseltamivir phosphate) drugs market.

Some of the major players operating in the tamiflu (oseltamivir phosphate) drugs market are:

• Pfizer Inc. (U.S.)
• GlaxoSmithKline plc (U.K.)
• Novartis AG (Switzerland)
• Mylan N.V. (U.S.)
• Teva Pharmaceutical Industries Ltd.(Israel)
• Sanofi (France)
• F. Hoffmann-La Roche Ltd. (Switzerland)
• Zydus Cadila (India)
• Lupino (India)
• Amneal Pharmaceuticals LLC. (Estados Unidos)
• Cipla Inc. (Estados Unidos)
• NATCO Pharma Limited (India)
• Macleods Pharmaceuticals Ltd (India)
• Strides Pharma Science Limited (India)
• Alembic Pharmaceuticals Limited (India)
• Heterosexual (India)
• Alvogen (Estados Unidos)
• Industrias farmacéuticas Sun Ltd. (India)
• Zydus Cadila (India)
• Lotus International (Estados Unidos)

SKU-53319